论文信息 - Significance of follow‐up thoracic imaging in myasthenia gravis

Significance of follow‐up thoracic imaging in myasthenia gravis

Most patients with myasthenia gravis (MG) undergo thoracic imaging at initial diagnosis. However, the follow‐up protocol is unclear. The objective of the present study was to clarify the follow‐up status and main findings of thoracic imaging in patients with MG.

[1] R. Iorio,et al. Characteristics of myasthenia gravis with antibodies to muscle‐specific kinase and low‐density lipoprotein‐related receptor protein 4 , 2015 .

[2] K. Fujihara,et al. Health‐related quality‐of‐life and treatment targets in myasthenia gravis , 2014, Muscle & nerve.

[3] J. Kira,et al. Clinical features and treatment status of adult myasthenia gravis in Japan , 2014 .

[4] Shigeaki Suzuki,et al. Clinical and immunological predictors of prognosis for Japanese patients with thymoma-associated myasthenia gravis , 2013, Journal of Neuroimmunology.

[5] M. Farrugia,et al. Delayed presentation of invasive thymoma in myasthenia gravis: A case report , 2011, Neuromuscular Disorders.

[6] Y. Yamanashi,et al. Autoantibodies to low‐density lipoprotein receptor–related protein 4 in myasthenia gravis , 2011, Annals of neurology.

[7] N. Levin,et al. Extrathymic malignancies in patients with myasthenia gravis , 2005, Journal of the Neurological Sciences.

[8] A. Vincent,et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies , 2001, Nature Medicine.

[9] A. Vincent,et al. Passive transfer of seronegative myasthenia gravis to mice , 1994, Muscle & nerve.

[10] D. B. Drachman,et al. Myasthenia gravis. , 1994, The New England journal of medicine.

[11] D. Elmqvist. Myasthenia Gravis , 1975, The Lancet.